Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Jan 2014. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 77277501000001117 | Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler 30 dose (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 77277601000001118 | Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler 30 dose | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler 30 dose | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler 30 dose | Is a | Virtual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler 30 dose | Has VMP | Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler 30 dose | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler 30 dose | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler 30 dose | Has specific active ingredient | Fluticasone furoate | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler 30 dose | Has specific active ingredient | Vilanterol | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler 30 dose | Has dispensed dose form | Conventional release powder for inhalation | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler 30 dose | Has specific active ingredient | Vilanterol | true | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR